- Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodiumM Anthony
The Critical Path Institute, Tucson, Arizona, USA
Clin Pharmacol Ther 86:425-9. 2009..This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin...
- The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseasesK Romero
Coalition Against Major Diseases, Critical Path Institute, Tucson, Arizona, USA
Clin Pharmacol Ther 86:365-7. 2009..The coalition's purpose is to transform the drug development paradigm for neurodegenerative diseases and serve as a model for other major diseases...